Navigation Links
U.S. Genomics Inc. Receives $4.5 Million Investment from BD
Date:9/23/2008

effective patient treatment and better outcomes."

DLA technology, developed with support from venture capital investors, NSF, DARPA, and the U.S. Department of Homeland Security (DHS), also has the potential to be applied in applications such as patient screening, hospital monitoring, epidemiology and forensics. U.S. Genomics currently has an extremely sensitive and accurate sensor for detection of biological threats in development under the DHS Bioagent Autonomous Network Detector program. Similar precision is required in hospital settings, where regulations may restrict reimbursement for costs associated with certain infections that occur as a result of hospital procedures. DLA has the potential to rapidly and accurately resolve whether a patient who became sick during a hospital stay was infected with a known hospital-based organism, or a strain not previously seen.

"We see tremendous potential for application of DLA technology," Canepa continued. "Working closely with BD on this collaboration, we plan to prioritize development efforts toward the multi-billion dollar infectious disease testing market. Further, the flexibility of the DLA technology to address a wide range of sample types creates future opportunities for U.S. Genomics to expand into significant new application areas, such as bio- security, bio-surveillance, and environmental and food safety testing."

About U.S. Genomics, Inc.

U.S. Genomics is pioneering single molecule biology technologies for diagnostics and biodefense applications by combining advanced microfluidics, optical engineering, and novel labeling strategies. Using its DNA mapping technology, the Company is developing sophisticated biological sensors for the detection and identification of pathogens and biomarkers in the air and other biologically relevant materials. The Company's biodefense focus on airborne pathogens has been funded in part by contracts from the U.S. Department of Homeland Security Science a
'/>"/>

SOURCE U.S. Genomics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
4. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
5. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
6. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
7. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
8. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
9. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
10. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... As a symbol of its commitment to ... manufacturing clients, Whitehouse Laboratories is excited to announce that ... Team for the 2015 race season. Success on the ... strong sense of precision and attention to detail. These ... the quality control testing laboratory. Sponsorship of the race ...
(Date:3/27/2015)... , 27. März 2015  Peter ... in Biomedical Science für seine bahnbrechende Arbeit ... zwischen Zellkompartimenten transportiert werden, sowie für die ... zur Reaktion auf Stress nutzen, der mit ... Walter ist Professor für Biochemie an der ...
(Date:3/27/2015)... 27, 2015  Peter Walter was chosen as winner ... pioneering work on how proteins are transported between cellular ... mechanism that cells use to handle stress tied to ... professor of biochemistry at the University of California, San ... range of human diseases related to defective protein folding ...
(Date:3/27/2015)... ROCKVILLE, Md. , March 27, 2015  CASI ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a commercial focus on ... the three and 12 months ended December 31, 2014.  ... of ($1.6 million), or ($0.05) per share, for the ...
Breaking Biology Technology:Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 2German-born cell biologist Peter Walter wins the 2015 Vilcek Prize in Biomedical Science 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6
... applying stem cell technology to an,orphan disease, in ... and IRVINE, Calif., July 29 ,ALS Therapy Development ... announced today a new collaboration aimed at advancing ... - amyotrophic lateral sclerosis,commonly known as Lou Gehrig,s ...
... July 29 Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ... development of drugs for the treatment of human ... results,for the second quarter ended June 30, 2008. ... marketable securities totaled $80.6 million., 2008 Year-to-Date ...
... 2008 American College of Chest Physicians (ACCP) Guidelines Will ... Use of Trellis(R) Peripheral ... American College of Chest,Physicians (ACCP) has published new evidence-based ... the use of pharmacomechanical,thrombolysis for acute iliofemoral deep vein ...
Cached Biology Technology:ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration 2ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration 3Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 2Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 3Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 4Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 5Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 7Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT 2
(Date:3/12/2015)... Beta Systems today announced ... management (IAM) solution for a fixed price and ... new IAM package, customers benefit from the 30 ... IAM implementations across different industries. The new fixed-price ... any necessary services and consulting. It spans the ...
(Date:3/11/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ... Control Market by Product, Application & By Geography - ... their offering. , This report predicts that ... billion by 2020, with an estimated CAGR of 10.6%. ... products types such as contact cards & readers, contactless ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... and the Veterans Affairs Greater Los Angeles Healthcare System ... the cost-effectiveness of current modern drugs for treating hepatitis ... Published in the May 17 Annals of Internal Medicine, ... decisions. Researchers note that a degree of uncertainly exists ...
... known for a long time that only 2% -- 3% ... of our genomes -- often referred to as junk DNA ... RNA, reverse-transcribed into DNA, and then reinserted into a new ... class of these retroelements. Retroviruses can insinuate themselves into the ...
... Don't miss out the cool movies, link at the end ... Medicine researchers have found a way to exercise a little ... their wings, and fly on command by triggering genetic "remote ... central nervous systems, according to a new report in the ...
Cached Biology News:UCLA study assesses cost-effectiveness of Hepatitis B drugs 2UCLA study assesses cost-effectiveness of Hepatitis B drugs 3Chimp genome reveals a retroviral invasion 2Chimp genome reveals a retroviral invasion 3Remote control flies? Fly behavior controlled by laser light 2Remote control flies? Fly behavior controlled by laser light 3
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...
... index chromatography system, uses the highly sensitive ... processing is provided by the CE 4900 interface ... pressure CE 4100 dual piston pump. A ... The system can be upgraded to provide binary ...
capacity 250 mL...
Rabbit polyclonal to YANK2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide selected within aa 300~400 (C terminal region) of human YANK2. Entrez Gene ID:...
Biology Products: